IPDN fell about -36% in regular trading to roughly $3.47, down from the prior session's close of $5.42. The drop is a sharp giveback after Tuesday's +38.97% surge, which followed a +16% gain on Sept 22.

XXII is down -38.89% during regular trading to roughly $1.43, extending an after-hours slide that began after Wednesday's +29% surge to a $2.34 close. The move is driven by a report that the FDA and administration plan to fast-track authorization for newer tobacco products such as flavored vapes, threatening 22nd Century's status as the only FDA-authorized reduced-nicotine cigarette maker (VLN).

WHLR is trading down -45.22% to $2.98 during regular market hours, reversing the prior session's +190.91% surge to a $5.44 close. The decline is a sharp pullback/profit-taking after a 1-for-9 reverse stock split sparked extreme, speculative volatility, with split-adjusted trading beginning September 22.

BENF is down -51.03% to $1.42 in the regular session, giving back a large portion of the prior session's +438.73% surge to a $2.90 close. The selloff is primarily profit-taking after Wednesday's explosive rally, which was driven by a plan to eliminate roughly $130 million in disputed debt and ~$850 million in preferred equity tied to convicted former CEO Brad Heppner.

HVIIU units declined roughly 57% over the past 30 days, from about $10.78 to $4.63, with most of the move concentrated in late September. The decline is structural rather than an earnings-driven selloff: Hennessy VII completed its business combination with ONE Nuclear Energy on September 23, 2026, and the combined company now trades under the ticker ONEN .

Two different AI plays: BE sells on-site fuel-cell power for data centers, while ORCL builds the cloud infrastructure and databases those facilities run on. Momentum gap: BE has delivered triple-digit gains over the past year on surging AI power demand, whereas ORCL has fallen sharply from its record high despite strong revenue growth.

SRZN surged roughly +104.7% intraday to about $33, up from a $16.16 prior close, during regular Nasdaq trading. Buying was driven by news around its SZN-8141 program, a bifunctional Wnt agonist/VEGF antagonist antibody for diabetic macular edema (DME).

ALMS is trading down -1.88% to about $7.30 during regular market hours, extending the prior session's -8.26% decline. No major company-specific headline hit today; the move reflects continued post-LUMUS selling pressure.

MAAS is trading down -14.67% to about $12.85 during regular market hours, versus a prior-session close of $15.06. The primary catalyst is dilution concerns: the company announced a roughly $50 million PIPE private placement at $12.89 per share, pricing new shares near a steep discount.

SKHX has surged roughly 78% over the last 30 days, rebounding from about $9.89 to approximately $17.62, as underlying SK Hynix shares rallied on an AI-driven memory boom. The fund delivers 2x daily leveraged exposure to a single stock, SK Hynix, so its moves are roughly double the underlying's daily changes and carry amplified volatility.

CRMG is a single-stock leveraged exchange-traded fund (ETF) that targets 2x (200%) the daily return of CRM , so its performance is dominated by Salesforce's share price. The fund has climbed roughly +58% over the trailing 30 days, from about $5.94 to $9.39.

SSK gained roughly 17% over the trailing 30 days, climbing from about $13.24 to near $15.51 per share. Over the past quarter, the fund has rallied more than 55% , rebounding sharply from its 52-week low of $8.37 set in early June.

BSOL gained roughly 18% over the last 30 days, tracking a sharp rally in Solana (SOL), the digital asset that underlies the fund. Over the past quarter, the fund has advanced approximately 77%, reflecting a broad recovery in Solana from its mid-year lows.

BHYP has advanced roughly 14% over the past 30 days, extending a broader gain of more than 50% over the trailing three months. The fund provides 100% spot exposure to HYPE, the native token of the Hyperliquid on-chain derivatives exchange, so its returns track HYPE's price directly.

MGM Resorts (MGM) fell -10.04% to $34.05 during Thursday's regular session, down from Wednesday's close of $37.85. The slide began in after-hours trading Wednesday after Barry Diller's People Inc. withdrew its $48.30-per-share cash buyout offer, which had valued MGM at over $18 billion.

SNX fell -9.05% to $261.85 during regular trading, down from a prior-session close of $287.89. The drop followed fiscal Q3 2026 results reported before the open: record revenue +37.7% to $21.56B and non-GAAP EPS of $5.68 versus a ~$4.70 consensus.

Everpure (P) is trading up +17.44% near $128.77 versus a prior close of $109.65, after gaining about +7% in premarket and extending higher during the regular session. The move was driven by its 2026 Financial Analyst Meeting, where the company issued a preliminary FY2028 revenue outlook of $7.0B–$7.3B (39%–45% growth), well above consensus near $6.3B.

BE is trading down -5.91% to $258.94 during regular market hours, after falling from a prior close of $275.19. The selloff began in premarket, where shares dropped nearly -7% before extending losses after the open.

Oracle (ORCL) fell -5.33% to about $136.85, down -$7.71 from the prior session's close of $144.56, during regular market hours. The primary catalyst: a report that Oracle is seeking "force majeure" protection on a major data-center project, signaling possible delays on its New Mexico "Project Jupiter" campus tied to the Stargate AI buildout.

VOYG is down -16.87% intraday to $31.20, versus a prior close of $37.53, after opening higher near $38. The decline unfolded during the regular session, extending an early premarket drop of roughly -6%.